0001104659-20-090308.txt : 20200804
0001104659-20-090308.hdr.sgml : 20200804
20200804163155
ACCESSION NUMBER: 0001104659-20-090308
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200731
FILED AS OF DATE: 20200804
DATE AS OF CHANGE: 20200804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLOCH KATHLEEN P.
CENTRAL INDEX KEY: 0001409212
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 201073762
MAIL ADDRESS:
STREET 1: 3 PERSHING COURT
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tm2026522d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-07-31
0
0001175151
Cytosorbents Corp
CTSO
0001409212
BLOCH KATHLEEN P.
C/O CYTOSORBENTS CORPORATION
7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION
NJ
08852
0
1
0
0
Chief Financial Officer
Common Stock
2020-07-31
4
M
0
10000
5.60
A
325156
D
Common Stock
21000
I
See Footnote
Stock Option (right to buy)
5.60
2020-07-31
4
M
0
10000
0
A
2027-02-24
Common Stock
10000
55650
D
Includes: (i) the following RSUs that will be settled into common stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the Company's 2014 Long-Term Incentive Plan (the "Plan"): (a) 15,700 RSUs granted on February 24, 2017, (b) 47,000 RSUs granted on June 7, 2016, (c) 110,000 RSUs granted on April 8, 2015, and (d) 8,800 RSUs granted on March 15, 2018; (continue with footnote 2)
(ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock, par value $0.001 per share (the "Common Stock") of the Company upon vesting: (a) 28,667 RSUs granted on February 28, 2020 and unvested as of the date hereof, (b) 14,334 RSUs granted on July 22, 2019 and unvested as of the date hereof and (c) 1,358 RSUs granted on March 4, 2019 and unvested as of the date hereof; and (iii) 99,297 shares of Common Stock owned by the Reporting Person.
Includes (i) 10,000 shares held by the Reporting Person's husband in a 401(k) account and (ii) 11,000 shares held by the Reporting Person's husband in an IRA account. The Reporting Person may be deemed the beneficial owner of such shares.
These stock options were originally granted on February 24, 2017 and became exercisable upon achievement of certain performance goals as determined in the discretion of the Compensation Committee of the Board of Directors of the Company.
/s/ Kathleen P. Bloch
2020-08-04